85% of all nonbacterial outbreaks of gastroenteritis in Europe and are typically detected in stool by reverse transcription poly'/> Evaluation of a commercial ELISA kit for the detection of Norovirus antigens in human stool specimens
首页> 外文期刊>Mitteilungen aus Lebensmitteluntersuchung und Hygiene >Evaluation of a commercial ELISA kit for the detection of Norovirus antigens in human stool specimens
【24h】

Evaluation of a commercial ELISA kit for the detection of Norovirus antigens in human stool specimens

机译:用于检测人粪便样本中诺如病毒抗原的商业ELISA试剂盒的评估

获取原文
获取原文并翻译 | 示例
       

摘要

Noroviruses (NV, formerly "Norwalk-like viruses") are responsible for >85% of all nonbacterial outbreaks of gastroenteritis in Europe and are typically detected in stool by reverse transcription polymerase chain reaction (RT-PCR) or electron microscopy. More rapid and less expensive methods like the ELISA (enzyme-linked immunosorbent assay) for detection of NVs in stool samples are now commercially available. The ELISA kit IDEIA~(TM) (DakoCytomation, Ely, UK) for the detection of NV antigens in stool samples and the simultaneous determination of the NV genogroup was evaluated. The performance of the ELISA was compared with an RT-PCR by testing stool samples collected from patients involved in NV outbreaks of gastroenteritis from Switzerland and Germany. We tested 39 Swiss stool samples and found for the ELISA a sensitivity and specificity of 43 % and 83 % respectively. When tested with German stool samples, the ELISA had a sensitivity and specificity of 46% and 100% respectively. Due to its low sensitivity, the ELISA kit is unsuitable for the Swiss Cantonal Laboratories and for medical diagnostic laboratories, which mostly investigate sporadic NV cases with a small number of samples provided. The ELISA kit could be useful as a NV screening method for investigating outbreaks of gastroenteritis in institutions missing specialised molecular detection methods but having a high number of possible NV cases, for example hospitals.
机译:诺如病毒(NV,以前称为“ Norwalk样病毒”)占欧洲胃肠炎所有非细菌性暴发的> 85%,通常通过逆转录聚合酶链反应(RT-PCR)或电子显微镜在粪便中检测到。现在可以从市场上买到更快,更便宜的方法,例如用于检测粪便中NV的ELISA(酶联免疫吸附测定)。评估了用于检测粪便样品中NV抗原并同时测定NV基因组的ELISA试剂盒IDEIA〜TM(DakoCytomation,Ely,UK)。通过测试从瑞士和德国的肠胃炎NV暴发患者收集的粪便样本,将ELISA的性能与RT-PCR进行了比较。我们测试了39个瑞士粪便样品,发现ELISA的灵敏度和特异性分别为43%和83%。用德国粪便样品进行测试时,ELISA的灵敏度和特异性分别为46%和100%。 ELISA试剂盒灵敏度低,因此不适用于瑞士州实验室和医学诊断实验室,这些实验室主要调查零星的NV病例,并提供少量样品。 ELISA试剂盒可作为NV筛查方法,用于在缺少专门的分子检测方法但有大量可能的NV病例的机构(例如医院)中调查肠胃炎的暴发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号